Pee Safe exit hits 9.6x
Early investor Venture Catalysts completed an exit from hygiene startup Pee Safe and returned roughly 9.6x on its original stake—an example of a strong consumer‑sector multiple in recent early exits (viestories.com). The outcome underscores continued buyer interest in consumer health and hygiene plays even as macro noise persists (viestories.com).
The deal was carried out as a secondary component of Pee Safe’s $32 million round led by healthcare investor OrbiMed, lifting the startup’s total raised to about $45.55 million. (economictimes.indiatimes.com)) Reports place the secondary sale in January–February 2026, and Venture Catalysts says the transaction delivered an XIRR of 30.53% for its fund and limited partners. (viestories.com)) Venture Catalysts first backed Pee Safe in August 2017 at a pre-money valuation of Rs 15 crore, investing roughly Rs 1.6 crore, and the exit was executed at a company valuation reported at about Rs 275 crore. (economictimes.indiatimes.com)) Pee Safe’s filed financials show operating revenue rose to Rs 82 crore in FY25 from Rs 56 crore in FY24, while the brand reports distribution through more than 50,000 offline retail touchpoints across 100+ cities and 45–50% year‑on‑year growth in the past two years. (economictimes.indiatimes.com)) Venture Catalysts said several other early backers – including We Founder Circle, Alkemi Growth Capital and Alpha Capital – also sold down in the round, while investors such as Zerodha‑backed Rainmatter and Natco Pharma remained on the cap table. (economictimes.indiatimes.com)) OrbiMed’s entry includes board representation and the company plans to use the fresh capital to deepen offline retail, ramp up brand marketing and expand quick‑commerce and marketplace reach. (techinasia.com))
